Misogyny in Medicine

Medicine is built on observation, evidence, and the admirable human habit of asking, “What is causing this?” Yet for centuries, when the patient was a woman, the answer was sometimes an unscientific variation of “probably emotions.” The vocabulary has changed, the white coats have become more comfortable, and electronic records now provide exciting new ways to misspell a patient’s namebut gender bias in healthcare has not disappeared.

Misogyny in medicine does not always arrive as an openly hostile doctor making an obviously sexist remark. More often, it operates quietly: a woman’s pain is underestimated, her symptoms are attributed to anxiety before physical causes are investigated, or a treatment guideline is built on research that included too few women. It can also shape the careers of women physicians through unequal pay, harassment, limited advancement, and expectations that they provide endless empathy without requiring time, authority, or compensation.

Understanding medical misogyny is not about declaring every disappointing appointment an act of discrimination. It is about recognizing repeated patterns, measuring their consequences, and redesigning healthcare so that credibility is not distributed according to gender.

What Does Misogyny in Medicine Mean?

Misogyny in medicine refers to beliefs, practices, institutional structures, and research traditions that devalue women, distrust their accounts, or treat male bodies and experiences as the default. It may be intentional, but it frequently survives without anyone consciously deciding to discriminate.

A clinician may sincerely believe that every patient is treated equally while unconsciously interpreting the same behavior differently. A man firmly describing severe pain may be viewed as direct and credible. A woman doing the same thing may be described as emotional, demanding, anxious, or “a difficult historian.” The bias is rarely announced with trumpets. It usually enters the room wearing sensible shoes and carrying a clipboard.

Sex and Gender Are Related but Different

Biological sex can influence anatomy, hormones, drug metabolism, disease presentation, and treatment response. Gender affects social expectations, exposure to violence, caregiving responsibilities, income, occupational risks, and how symptoms are interpreted by patients and professionals. High-quality medicine must consider both without assuming that every woman has the same body, identity, risks, or healthcare needs.

Medical misogyny can affect cisgender women as well as transgender men, transgender women, nonbinary people, and others whose bodies or identities do not fit traditional assumptions. Bias also intersects with racism, disability, age, poverty, body size, sexuality, immigration status, and geography. Consequently, some patients experience several layers of disbelief at once.

The Historical Roots of Gender Bias in Healthcare

Modern medicine did not invent misogyny, but it occasionally gave old prejudices impressive Latin names. For centuries, women’s physical and psychological symptoms were associated with “hysteria,” a diagnosis historically linked to the uterus. The label became a convenient container for distress, pain, seizures, fatigue, sexual concerns, and behaviors that challenged social expectations.

Not every physician who used the diagnosis acted maliciously, and medical understanding was limited for everyone. Still, the historical record shows a persistent tendency to interpret women’s symptoms through assumptions about emotion, sexuality, reproduction, and obedience. Those assumptions did not vanish when “hysteria” fell out of routine diagnostic use; some simply changed outfits and reappeared as premature conclusions about stress, anxiety, or exaggeration.

When the Male Body Became the Medical Default

Gender bias also became embedded in research. In 1977, the U.S. Food and Drug Administration recommended excluding women of childbearing potential from early phases of many drug trials. The policy was influenced by legitimate concerns about fetal exposure following tragedies involving drugs such as thalidomide, but its broad application excluded many women regardless of their actual pregnancy risk.

This protective approach created another danger: medications could reach the market without adequate information about their effects in women. Researchers often treated male animals, male cells, and male participants as simpler or more universal study subjects. Female hormonal cycles were framed as inconvenient research “noise,” as though half the population had failed to organize its biology around the laboratory calendar.

The NIH Revitalization Act of 1993 directed the National Institutes of Health to establish guidelines for including women and racial and ethnic minority groups in clinical research. NIH later introduced its Sex as a Biological Variable policy, requiring researchers to consider sex in study design, analysis, and reporting. These reforms were important, but reviews continue to find underrepresentation, weak sex-specific analysis, and gaps in the reporting of outcomes.

How Medical Misogyny Appears in Patient Care

Pain Is Heard, but Not Always Believed

Pain is subjective, which makes communication essential. It also leaves room for stereotypes to influence decisions. Studies have found sex-related disparities in pain assessment and treatment, including research showing that women presenting with acute abdominal pain were less likely to receive opioid analgesics than men and waited longer for treatment. More recent experimental research has similarly found that female patients may be perceived as experiencing less pain and may be less likely to receive pain-relieving medication, even when their reported symptoms are comparable.

This does not mean every woman with pain is undertreated or every man is treated promptly. It means that, across groups, gender can influence whose suffering appears urgent, credible, or medically significant. For women of color, gender bias can combine with racial myths about pain tolerance, producing an especially dangerous credibility gap.

Heart Disease Is Not a “Man’s Problem”

Cardiovascular disease has long been culturally framed as a male condition, despite being a leading cause of death among women. Women can experience classic heart attack symptoms such as chest pressure, but they may also report nausea, unusual fatigue, shortness of breath, jaw discomfort, or back pain. When both clinicians and patients expect a Hollywood-style chest-clutching scene, subtler presentations can be overlooked.

American Heart Association reporting and research have documented continuing treatment gaps. Women may receive fewer guideline-directed medications, experience delays in evaluation, or be less likely to undergo certain procedures. One study of emergency department visits found that women with chest pain waited longer for an initial evaluation than men and were less likely to be admitted or kept for observation.

Biological differences matter, but biology alone cannot explain every disparity. Research participation, clinical education, risk-assessment tools, social expectations, and implicit bias all influence whether cardiovascular symptoms are recognized and treated promptly.

Reproductive Pain Is Too Often Normalized

Menstruation can involve discomfort, but severe pain that disrupts work, school, sleep, mobility, or daily life should not automatically be dismissed as “just a bad period.” Conditions such as endometriosis can cause pelvic pain, painful sex, gastrointestinal symptoms, fatigue, infertility, and pain outside menstruation.

Studies consistently describe long diagnostic journeys for endometriosis, with commonly reported delays of approximately seven to ten years. Patients often encounter symptom normalization, repeated prescriptions without a full evaluation, inconclusive imaging, and assumptions that pain is ordinary or psychological. Research has also linked experiences of dismissal with longer delays before diagnosis.

Diagnostic delay is not always caused by prejudice. Endometriosis is genuinely complex, symptoms overlap with other conditions, and standard imaging does not identify every case. However, complexity should lead to careful follow-upnot to a conversational trapdoor through which the patient disappears.

Maternal Health Reveals the Cost of Intersectional Bias

Maternal mortality is one of the clearest examples of unequal healthcare outcomes in the United States. According to CDC data for 2023, the maternal mortality rate among non-Hispanic Black women was 50.3 deaths per 100,000 live births, compared with 14.5 among non-Hispanic White women, 12.4 among Hispanic women, and 10.7 among non-Hispanic Asian women.

The reasons are complex and include differences in underlying health, insurance, access to high-quality facilities, social determinants of health, and continuity of care. Structural racism and implicit bias also matter. Education, professional status, or income does not automatically protect Black women from having symptoms minimized or concerns overlooked.

Preventing these deaths requires more than advising pregnant patients to advocate harder. Hospitals must respond consistently to warning signs, examine disparities in their own outcomes, improve postpartum care, and treat patient reports as clinical evidence rather than optional commentary.

Misogyny Within the Medical Profession

Women are not only affected as patients. Women physicians, researchers, nurses, trainees, and other healthcare professionals can encounter harassment, unequal compensation, limited sponsorship, biased evaluations, and expectations that they perform more unrecognized service work.

Pay and Promotion Gaps

Compensation varies according to specialty, hours, procedures, seniority, geography, leadership roles, and practice type. Even after accounting for many relevant factors, however, analyses have continued to identify gender-based pay differences among physicians. AAMC reporting has found that gender is a major driver of compensation inequities and that men frequently receive higher median compensation than women of the same racial or ethnic group.

Career advancement is shaped long before a final salary is negotiated. Who receives mentorship? Who is introduced to influential colleagues? Who is encouraged to apply for leadership? Who gets protected research time, credit for collaborative work, and forgiveness for being confidently wrong during rounds? Small advantages accumulate.

Harassment and Hostile Work Environments

The National Academies has reported that women students in academic medicine experience particularly high levels of sexual harassment compared with students in several other academic fields. Gender harassment may include degrading comments, sexist hostility, exclusion, and behavior communicating that women do not belong. It does not have to involve a sexual proposition to damage careers, mental health, productivity, or retention.

Traditional medical hierarchies can make reporting especially difficult. A trainee may depend on the alleged harasser for evaluations, recommendations, research access, or future employment. A complaint system is not truly safe when using it may quietly end the complainant’s career while the institution announces that it takes concerns “very seriously.”

Not Every Medical Error Is Misogyny

Diagnostic uncertainty is unavoidable. Symptoms overlap, tests can be misleading, diseases evolve, and clinicians work under intense time pressure. A delayed diagnosis does not automatically prove gender bias, and respectful disagreement is not discrimination.

The stronger evidence for medical misogyny comes from patterns: repeated disparities across large groups, different responses to comparable symptoms, consistent underinvestment in certain conditions, biased language in records, unequal workplace outcomes, and patient accounts that align with measurable differences in care.

This distinction matters. Calling every mistake misogyny can make the concept less useful. Refusing to examine any mistake for bias makes improvement impossible. The goal is not to assign a cartoon villain to every hospital corridor. It is to identify where assumptions alter decisions and where systems repeatedly produce unequal results.

The Consequences of Gender Bias in Healthcare

When patients are not believed, they may undergo delayed testing, inadequate pain control, worsening disease, preventable complications, and repeated appointments. Some stop seeking care entirely. Others arrive at future visits armed with binders, symptom spreadsheets, photographs, timelines, and the expression of someone preparing to defend a doctoral dissertation titled Yes, This Is Actually Happening to My Body.

The psychological consequences also matter. Medical gaslighting can lead patients to doubt their perceptions, minimize symptoms, or believe they are wasting clinicians’ time. Trust declines not only in one practitioner but sometimes in the entire healthcare system.

For professionals, discrimination contributes to burnout, reduced productivity, stalled careers, and departure from academic medicine. This harms institutions as well as individuals. Evidence from several large observational studies has associated care by women physicians with outcomes that are at least comparableand in some analyses modestly betterthan care by male physicians. Such findings do not establish that one gender is inherently superior, but they challenge any assumption that women’s advancement represents a compromise in quality.

How Healthcare Can Reduce Medical Misogyny

Listen Before Interpreting

Clinicians should document the patient’s own description of symptoms, ask how those symptoms affect daily life, and avoid assigning a psychological explanation before considering relevant physical causes. Anxiety can coexist with heart disease, endometriosis, autoimmune illness, neurological disease, and nearly every other condition. Once a patient has an anxiety diagnosis, the rest of the body does not resign.

Use Standardized Clinical Pathways

Protocols for chest pain, maternal warning signs, stroke symptoms, and pain management can reduce reliance on subjective impressions. Institutions should examine whether patients of different sexes, genders, races, or ethnicities experience different wait times, testing rates, medication use, referrals, complications, and outcomes.

Improve Research Design

Clinical trials should recruit populations that reflect those who will use the intervention. Researchers must analyze outcomes by sex when scientifically appropriate, report meaningful differences, and avoid assuming that findings from one group automatically apply to everyone. Women should also be included in leadership roles that determine research priorities and funding.

Change Workplace Incentives

Healthcare organizations should conduct transparent pay audits, standardize promotion criteria, reward mentorship, monitor evaluation language, and provide independent reporting channels for harassment. Leaders should be judged not merely on publication counts or revenue but also on whether their departments are safe, fair, and capable of retaining talented people.

Help Patients Participate Without Blaming Them

Patients can prepare a concise symptom timeline, list medications, describe functional limitations, and ask what diagnoses are being considered. Useful questions include, “What serious causes have been ruled out?” and “What is the follow-up plan if these symptoms continue?” Seeking a second opinion may be appropriate when concerns remain unresolved.

However, the burden cannot rest entirely on patients. A person in pain should not need perfect medical vocabulary, unusual confidence, or a color-coded binder to receive careful care.

Experiences That Reveal Misogyny in Medicine

The following are composite experiences based on patterns commonly described in patient narratives and medical research. They do not represent one identifiable individual.

Experience One: “It Is Probably Stress”

A 34-year-old woman develops episodes of rapid heartbeat, chest pressure, dizziness, and unusual exhaustion. She works full time and cares for two children, so stress is certainly present. At an urgent care visit, her symptoms are attributed to anxiety. She is advised to sleep more, reduce caffeine, and practice relaxation.

The advice is not unreasonable, but the evaluation ends too quickly. No one asks whether the symptoms occur during exertion, whether she has a family history of cardiac disease, or whether pregnancy complications increased her later cardiovascular risk. When she returns, visibly frustrated, her frustration becomes further evidence that the original anxiety explanation was correct.

Months later, a different clinician reviews the complete history, orders additional testing, and identifies a cardiac rhythm disorder. The problem was not that anxiety had been considered. The problem was that it became the conclusion before a sufficient investigation was completed. Her emotional response was treated as proof against her credibility instead of a predictable response to feeling unwell and unheard.

Experience Two: The “Normal” Period That Is Not Normal

A teenager begins experiencing severe pelvic pain shortly after her periods start. She vomits, misses school, and occasionally cannot stand upright, but relatives and clinicians tell her menstruation is supposed to hurt. Birth control pills help temporarily. When the pain returns, she receives another prescription rather than a broader assessment.

Over the next several years, she visits primary care offices, emergency departments, and gastrointestinal specialists. Her tests are often normal. Because no simple answer appears, the medical record gradually fills with words such as “anxious,” “tearful,” and “focused on symptoms.” These observations may be accurate, but they begin to influence how each new clinician interprets the case.

Eventually, a gynecologist recognizes a pattern consistent with endometriosis and develops a long-term management plan. The patient feels relieved but also angry. She did not expect the first clinician to diagnose a difficult condition instantly. She expected someone to notice that pain causing repeated vomiting and lost school days was not an ordinary inconvenience.

Experience Three: A Doctor Who Is Still Mistaken for Someone Else

A woman physician enters a hospital room with a male medical student. The patient directs clinical questions to the student, assuming he is the senior doctor. During meetings, colleagues interrupt her explanations but praise the same idea when a male colleague restates it. She receives excellent reviews for compassion and teamwork, yet feedback repeatedly encourages her to be “more confident.” When she communicates firmly, another reviewer describes her as abrasive.

She also spends more time answering messages, helping trainees, resolving team conflicts, and explaining treatment plans to families. This work improves care but produces fewer publications and billable procedures. When promotion decisions arrive, the institution rewards the visible metrics while treating her invisible labor as a pleasant personality trait.

No single event proves a coordinated campaign against her. That is precisely why the pattern is difficult to challenge. Each incident can be explained away as a misunderstanding, an individual preference, or ordinary workplace friction. Together, they shape authority, income, time, and advancement.

What These Experiences Have in Common

In all three cases, misogyny operates through credibility. The patient with cardiac symptoms is not fully believed. The teenager’s pain is normalized. The physician’s expertise is repeatedly underestimated. The result is not always an obvious catastrophe. Sometimes it is a slower accumulation of delays, missed opportunities, unnecessary suffering, and exhaustion.

These experiences also show why individual kindness is not enough. A healthcare system can contain many caring professionals and still produce biased outcomes. Good intentions must be supported by better research, clear protocols, transparent workplace policies, accountable leadership, and a culture that treats listening as a clinical skill rather than a customer-service bonus.

Conclusion

Misogyny in medicine is not merely an unpleasant relic stored beside antique surgical tools. It remains visible in research gaps, pain treatment, delayed diagnoses, maternal health disparities, cardiovascular care, workplace harassment, compensation, and leadership opportunities.

Progress has occurred. Women are better represented in medical education and clinical research than in previous generations. Federal policies now require greater attention to inclusion, and healthcare organizations increasingly measure disparities. Yet representation alone does not guarantee equity. A system can welcome women through the front door while continuing to discount their symptoms, underfund their conditions, or block their advancement upstairs.

The solution is neither to distrust every clinician nor to assume that bias explains every negative outcome. It is to apply the same principle medicine claims as its foundation: follow the evidence. When data reveal unequal care, investigate it. When patients repeatedly describe dismissal, listen carefully. When policies produce predictable disparities, redesign them.

Healthcare becomes more scientificnot lesswhen it questions inherited assumptions. The future of medicine should not require women to prove that their pain is real, their expertise is legitimate, or their lives are worth studying.